Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke

NCT02360137 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1863

Last updated 2023-07-28

No results posted yet for this study

Summary

Atherosclerosis is the most common cause of stroke. The aims of the project are to compare the visual and digital analysis of sonographic images of atherosclerotic plaque in carotids in vivo, in vitro and with a histological composition of the plaque obtained from patients indicated to carotid endarterectomy, to compare the characteristics of symptomatic and asymptomatic atherosclerotic plaques and, subsequently to verify a hypothesis that ultrasound can identify the sonographic plaque characteristics associated with an increased risk of plaque progression and of ischemic stroke (unstable plaque) in patients with carotid atherosclerosis. Identifying of the sonographic characteristics of unstable plaque will allow to improve indication criteria for carotid endarterectomy or stenting and also potential changing of a drug therapy in patients with unstable plaque in the future. Cost efficiency and availability of duplex ultrasound equipment may enable to improve diagnosis of unstable plaque using this new plaque characteristics evaluation in the majority of patients with carotid plaques.

Conditions

  • Carotid Artery Plaque

Sponsors & Collaborators

  • General Teaching Hospital, Prague

    collaborator OTHER
  • Charles University, Czech Republic

    collaborator OTHER
  • Palacky University

    collaborator OTHER
  • Military University Hospital, Prague

    collaborator OTHER
  • University of Ostrava

    collaborator OTHER
  • Masaryk Hospital Usti nad Labem

    collaborator OTHER
  • University Hospital Hradec Kralove

    collaborator OTHER
  • Na Homolce Hospital

    collaborator OTHER
  • University Hospital Olomouc

    collaborator OTHER
  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • David Skoloudík, MD, Prof · University Hospital Ostrava

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2026-01-01
Completion
2026-06-01

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02360137 on ClinicalTrials.gov